Urgent call to update MS prescribing restrictions

PRESCRIBING restrictions for multiple sclerosis medications urgently need to be adjusted in light of potentially dangerous side effects, say a team of Australian specialists. 

Current recommendations and indications for MS therapies are inconsistent, and with new evidence now available, prescribing restrictions need to be updated, the authors of an MJA Clinical Focus article write. 

While we are in an “exciting era” for MS treatment, “most of the newer, more effective therapies are associated with risks and practical problems that necessitate an